DT Investment Partners’s Edwards Lifesciences EW Stock Holding History

DT Investment Partners’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.33K	Hold	81	–	–	﹤0.01%	418
2026 Q1	$6.49K	Hold	81	–	–	﹤0.01%	429
2025 Q4	$6.91K	Hold	81	–	–	﹤0.01%	457
2025 Q3	$6.3K	Hold	81	–	–	﹤0.01%	456
2025 Q2	$6.34K	Hold	81	–	–	﹤0.01%	446
2025 Q1	$5.87K	Hold	81	–	–	﹤0.01%	465
2024 Q4	$6K	Hold	81	–	–	﹤0.01%	473
2024 Q3	$5.35K	Buy	81 +60	+286%	+$4.36K	﹤0.01%	513
2024 Q2	$1.94K	Hold	21	–	–	﹤0.01%	492
2024 Q1	$2.01K	Hold	21	–	–	﹤0.01%	434
2023 Q4	$1.55K	Hold	21	–	–	﹤0.01%	440
2023 Q3	$1.46K	Hold	21	–	–	﹤0.01%	438
2023 Q2	$1.72K	Hold	21	–	–	﹤0.01%	440
2023 Q1	$1.84K	Hold	21	–	–	﹤0.01%	441
2022 Q4	$1.57K	Hold	21	–	–	﹤0.01%	467
2022 Q3	$2K	Buy	+21	New	+$2.02K	﹤0.01%	429

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

DT Investment Partners's EW Position: Q2 2026 in Review

DT Investment Partners held its Edwards Lifesciences (EW) position steady in Q2 2026 at 81 shares worth $7.33K. The position accounts for ﹤0.01% of the portfolio, ranked #418.

DT Investment Partners first reported a position in EW in Q3 2022 and has held it in 16 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

DT Investment Partners held 81 shares of Edwards Lifesciences worth $7.33K as of Q2 2026.
DT Investment Partners left its Edwards Lifesciences share count unchanged in Q2 2026.
Edwards Lifesciences made up ﹤0.01% of DT Investment Partners's portfolio in Q2 2026, its #418 holding.
DT Investment Partners first reported a position in Edwards Lifesciences in Q3 2022 and has held it in 16 quarters since.
1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on DT Investment Partners's 13F filing for Q2 2026, filed 27 Jul 2026.